Wellbutrin News and Research

RSS
Wellbutrin is a prescription medicine used to treat adults with a certain type of depression called major depressive disorder and for prevention of autumn-winter seasonal depression (seasonal affective disorder).
USPTO issues Notice of Allowance for IntelGenx's bupropion patent

USPTO issues Notice of Allowance for IntelGenx's bupropion patent

Third-quarter financial results for the year 2009 announced by Biovail

Third-quarter financial results for the year 2009 announced by Biovail

Biomarkers for rapid identification of treatment effectiveness in major depression

Biomarkers for rapid identification of treatment effectiveness in major depression

Biovail's patent infringement lawsuit against Cary Pharma may affect IntelGenx revenues

Biovail's patent infringement lawsuit against Cary Pharma may affect IntelGenx revenues

Chantix and Zyban to get boxed warnings on serious mental health events

Chantix and Zyban to get boxed warnings on serious mental health events

GSK to divest U.S. rights for Wellbutrin XL to Biovail

GSK to divest U.S. rights for Wellbutrin XL to Biovail

New antidepressants might be no more effective than the best existing drugs

New antidepressants might be no more effective than the best existing drugs

Happy pills in America -- Our complex love affair with designer consciousness

Happy pills in America -- Our complex love affair with designer consciousness

Watson Pharmaceuticals receives FDA approval for generic Wellbutrin XL

Watson Pharmaceuticals receives FDA approval for generic Wellbutrin XL

Actavis receives approval of generic Wellbutrin in U.S.

Actavis receives approval of generic Wellbutrin in U.S.

Chantix for smoking cessation performs better than placebos

Chantix for smoking cessation performs better than placebos

When your antidepressants don't work

When your antidepressants don't work

Antidepressants might be worthless for treating low back pain

Antidepressants might be worthless for treating low back pain

Selective publication means unfavorable drug studies rarely get published

Selective publication means unfavorable drug studies rarely get published

FDA - all antidepressants need new warning labels

FDA - all antidepressants need new warning labels

Treatment options for bipolar disorder

Treatment options for bipolar disorder

New drug will treat those winter blues

New drug will treat those winter blues

FDA approves Wellbutrin X for treatment of seasonal depression

FDA approves Wellbutrin X for treatment of seasonal depression

Depression treatment may require different drugs for different people

Depression treatment may require different drugs for different people

Effects of 10 commonly prescribed second-generation antidepressants studied

Effects of 10 commonly prescribed second-generation antidepressants studied